FDA Partial Recognition of EN ISO 10993-1:2025

FDA partial regonition of ISO 10993-1. Alignement with ISO 14971 and risk estimation

The FDA officially recognized EN ISO 10993-1:2025 – “Biological evaluation of medical devices – Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process” on Monday, May 25, 2026. However, the Agency granted only a partial recognition! The 6th edition of ISO 10993-1 has been reshaped with a stronger […]

Environmental Risk Assessment of Medicinal Products: A Streamlined Regulatory Overview

Tox Hub Blog – Expert Insights on Toxicology & Regulatory Topics

The Environmental Risk Assessment (ERA) play a key role in regulatory submissions for medicines in the European Union. The European Medicines Agency (EMA) requires a clear, evidence-based process to assess the potential environmental impact of active pharmaceutical ingredients (APIs) that enter the environment through patient use. With the updated EMA guideline (EMEA/CHMP/SWP/4447/00 Rev. 1 – EMA […]

Companion Diagnostics: A Vital Component in Medical Device Advancements

Companion Diagnostics

In the rapidly evolving landscape of healthcare, precision medicine has emerged as a groundbreaking approach to tailor medical treatment to the individual characteristics of each patient. At the forefront of this revolution are companion diagnostics (CDx), an integral component of medical devices that holds the key to unlocking personalized and targeted therapies. Let’s explore the […]